Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001415889-25-000621

INTERIM CEO gave up 17,436 shares (to pay taxes)

  • INTERIM CEO acquired 38,616 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Walker Neal · INTERIM CEO

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2025-01-01 Exercise or conversion : show line 1 in the form +9,467 1,443,097 D
2025-01-01 Shares withheld for taxes : show line 2 in the form −3,904 $2.48 $9,682 1,439,193 D
2025-01-02 Exercise or conversion : show line 3 in the form +29,149 1,468,342 D
2025-01-02 Shares withheld for taxes : show line 4 in the form −13,532 $2.48 $33,559 1,454,810 D

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2025-01-01 Exercise or conversion : show line 5 in the form Restricted Stock Units −9,467 37,867 D
2025-01-02 Grant or award : show line 6 in the form Restricted Stock Units +88,333 88,333 D
2025-01-02 Exercise or conversion : show line 7 in the form Restricted Stock Units −29,149 59,184 D
Loading xslF345X05/form4-01032025_060101.xml…